1. Home
  2. GHRS vs UXIN Comparison

GHRS vs UXIN Comparison

Compare GHRS & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • UXIN
  • Stock Information
  • Founded
  • GHRS 2018
  • UXIN 2011
  • Country
  • GHRS Ireland
  • UXIN China
  • Employees
  • GHRS N/A
  • UXIN N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • UXIN Business Services
  • Sector
  • GHRS Health Care
  • UXIN Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • UXIN Nasdaq
  • Market Cap
  • GHRS 774.1M
  • UXIN 713.3M
  • IPO Year
  • GHRS 2021
  • UXIN 2018
  • Fundamental
  • Price
  • GHRS $13.11
  • UXIN $2.93
  • Analyst Decision
  • GHRS Strong Buy
  • UXIN
  • Analyst Count
  • GHRS 9
  • UXIN 0
  • Target Price
  • GHRS $29.33
  • UXIN N/A
  • AVG Volume (30 Days)
  • GHRS 319.1K
  • UXIN 299.7K
  • Earning Date
  • GHRS 11-13-2025
  • UXIN 11-24-2025
  • Dividend Yield
  • GHRS N/A
  • UXIN N/A
  • EPS Growth
  • GHRS N/A
  • UXIN N/A
  • EPS
  • GHRS N/A
  • UXIN N/A
  • Revenue
  • GHRS N/A
  • UXIN $340,011,237.00
  • Revenue This Year
  • GHRS N/A
  • UXIN $727.65
  • Revenue Next Year
  • GHRS N/A
  • UXIN N/A
  • P/E Ratio
  • GHRS N/A
  • UXIN N/A
  • Revenue Growth
  • GHRS N/A
  • UXIN 45.02
  • 52 Week Low
  • GHRS $6.72
  • UXIN $2.93
  • 52 Week High
  • GHRS $20.50
  • UXIN $7.48
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 47.63
  • UXIN 35.78
  • Support Level
  • GHRS $12.26
  • UXIN $3.24
  • Resistance Level
  • GHRS $13.65
  • UXIN $3.66
  • Average True Range (ATR)
  • GHRS 0.75
  • UXIN 0.26
  • MACD
  • GHRS -0.08
  • UXIN -0.03
  • Stochastic Oscillator
  • GHRS 31.37
  • UXIN 1.49

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

Share on Social Networks: